Antipodean Advisors LLC - Q3 2023 holdings

$19.5 Million is the total value of Antipodean Advisors LLC's 13 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 112.5% .

 Value Shares↓ Weighting
OXY BuyOCCIDENTAL PETE CORP$6,488,000
+100.6%
100,000
+81.8%
33.24%
+44.9%
PM NewPHILIP MORRIS INTL INC$4,629,00050,000
+100.0%
23.72%
SE  SEA LTDsponsord ads$3,076,500
-24.3%
70,0000.0%15.76%
-45.3%
ATRA  ATARA BIOTHERAPEUTICS INC$1,480,000
-8.1%
1,000,0000.0%7.58%
-33.6%
BuyINVESTMENT MANAGERS SER TR Iaxs tsla bear dl$1,299,200
+14.7%
40,000
+14.3%
6.66%
-17.1%
RILY NewB. RILEY FINANCIAL INC$435,68310,629
+100.0%
2.23%
CMAX SellCAREMAX INC$424,000
-67.9%
200,000
-52.9%
2.17%
-76.8%
DLR NewDIGITAL RLTY TR INC$423,5703,500
+100.0%
2.17%
TRUP NewTRUPANION INC$423,00015,000
+100.0%
2.17%
COIN NewCOINBASE GLOBAL INC$375,4005,000
+100.0%
1.92%
CDLX SellCARDLYTICS INC$330,000
+49.2%
20,000
-42.9%
1.69%
+7.8%
FUBO NewFUBOTV INC$81,16830,400
+100.0%
0.42%
OPEN NewOPENDOOR TECHNOLOGIES INC$52,80020,000
+100.0%
0.27%
CVNA ExitCARVANA COcl a$0-10,000
-100.0%
-1.84%
GDX ExitVANECK ETF TRUSTgold miners etf$0-75,000
-100.0%
-16.02%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CARVANA CO21Q2 202338.5%
AMAZON COM INC20Q4 202033.8%
SEA LTD19Q3 202360.8%
CARDLYTICS INC18Q3 202326.3%
MEDICINES CO18Q4 201919.8%
ATARA BIOTHERAPEUTICS INC15Q3 202317.9%
CONSTELLATION BRANDS INC14Q4 201611.1%
HERBALIFE NUTRITION LTD13Q1 202124.8%
CLARIVATE PLC11Q4 202124.4%
EXACT SCIENCES CORP11Q2 201924.6%

View Antipodean Advisors LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Antipodean Advisors LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Oncothyreon Inc.Sold outJanuary 09, 201300.0%

View Antipodean Advisors LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15
13F-HR2021-08-16

View Antipodean Advisors LLC's complete filings history.

Compare quarters

Export Antipodean Advisors LLC's holdings